Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease
Authors:
- 7 April 2010
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (9) , 1467-1472
Abstract
Acute painful episodes are the clinical hallmark of sickle cell disease and have been linked to morbidity and mortality in the sickle cell population. We undertook exploratory proteomic studies on paired plasma samples collected from a cohort of 26 adult sickle cell patients during steady state and on the first day of an acute painful episode. We screened for changes in abundance of specific protein peaks via surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF MS), and confirmed the identify of candidate protein peaks by specific immunoassays. The levels of hemoglobin, hematocrit, total protein, and albumin were lower and the levels of lactate dehydrogenase and absolute reticulocytes higher during acute painful episodes than during the steady state. Surface-enhanced laser desorption/ionization time of flight mass spectrometry spectral analysis consistently showed a mass-to-charge peak at 11.7 kDa with elevated intensities during acute painful episodes, which correlated significantly with the serum amyloid A immunoassay. Serum amyloid A levels were significantly elevated during acute painful episodes, especially in four patients with marked end-organ complications of such episodes. A second, recurring peak, less abundant during acute painful episodes, was present at 28.1 kDa; this peak was correlated significantly with immunoassay measurements of apolipoprotein A1. On the average, plasma serum amyloid A rises and apolipoprotein AI falls during acute painful episodes. The serum amyloid A/apolipoprotein AI ratio increased in 81% of the patients during acute painful episodes, potentially making it a useful objective marker of such episodes. We propose that these protein alterations, known to contribute to endothelial dysfunction in other settings, might do likewise acutely in acute painful episodes and present a new target for therapeutic intervention in sickle cell disease. (ClincalTrials.gov Identifier: NCT00081523).Keywords
This publication has 33 references indexed in Scilit:
- Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease [see comments]Blood, 1995
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- The painful crisis of homozygous sickle cell disease: clinical featuresBritish Journal of Haematology, 1994
- Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodesThe American Journal of Medicine, 1994
- Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.Journal of Clinical Pathology, 1994
- Is there an acute-phase response in steady-state sickle cell disease?The Lancet, 1993
- Subclinical ischaemic episodes during the steady state of sickle cell anaemia.Journal of Clinical Pathology, 1992
- Rheological changes in the prodromal and established phases of sickle cell vaso‐occlusive crisisBritish Journal of Haematology, 1992
- Is the painful crisis of sickle-cell disease due to sickling?The Lancet, 1991
- Creatine kinase activity in sickle cell disease.Journal of Clinical Pathology, 1989